4//SEC Filing
Petteway Stephen R Jr 4
Accession 0001225208-10-021987
CIK 0001405197other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:08 PM ET
Size
9.4 KB
Accession
0001225208-10-021987
Insider Transaction Report
Form 4
Petteway Stephen R Jr
Executive VP, R&D
Transactions
- Exercise/Conversion
Common Stock
2010-10-01$1.39/sh+20,000$27,800→ 85,198 total - Sale
Common Stock
2010-10-01$22.81/sh−25,000$570,150→ 60,198 total - Exercise/Conversion
Options (right to buy)
2010-10-01$1.39/sh−20,000$27,776→ 329,040 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2010.
- [F2]The number of shares reported includes / consists of restricted share units representing the right to receive 9,210 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.76 to $22.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange
- [F4]The option is fully vested and immediately exercisable.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472129
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:08 PM ET
- Size
- 9.4 KB